CIBC Private Wealth Group
BBNX

CIBC Private Wealth Group’s Beta Bionics BBNX Stock Holding History

CIBC Private Wealth Group’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$192K Buy
6,301
+6,300
+630,000% +$168K ﹤0.01% 1213
2025
Q3 		$20 Buy
+1
New +$18 ﹤0.01% 3048

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

CIBC Private Wealth Group's BBNX Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Beta Bionics (BBNX) stake by 630,000% in Q4 2025, buying an estimated $168K and bringing the position to 6,301 shares worth $192K. The position accounts for ﹤0.01% of the portfolio, ranked #1213.

CIBC Private Wealth Group first reported a position in BBNX in Q3 2025 and has held it in 2 quarters since. 158 funds tracked by Wall St. Rank hold BBNX as of Q4 2025.

  • CIBC Private Wealth Group held 6,301 shares of Beta Bionics worth $192K as of Q4 2025.
  • CIBC Private Wealth Group bought 6,300 Beta Bionics shares in Q4 2025, an estimated $168K.
  • Beta Bionics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1213 holding.
  • CIBC Private Wealth Group first reported a position in Beta Bionics in Q3 2025 and has held it in 2 quarters since.
  • 158 funds tracked by Wall St. Rank held Beta Bionics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.